Clinical trials
28 results
Applied filters
Additional considerations for single or multi-centre trials
29 April 2026Ensure the correct process is followed depending on whether it is a single or multi-centre trial sponsored by an NHS organisation.
Constructing a pharmacy manual for clinical trials
29 April 2026Sponsor pharmacy should construct a pharmacy manual when required by the sponsor to facilitate IMP and NIMP management by the different delivery location sites.
Updated clinical trials regulation: implementation considerations
26 February 2026An SPS Quality Assurance learning event on understanding the updated clinical trials regulation and practical considerations for pharmacy clinical trials sites.
In-vivo GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing in-vivo genetically modified organism (GMO) gene therapy.
Ex-vivo GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing ex-vivo genetically modified organism (GMO) gene therapy.
Tissue engineered products
13 February 2026This document outlines key areas for focus of pharmaceutical expertise prior to an organisation implementing tissue engineered products.
Ex-vivo non-GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing ex-vivo non-genetically modified organism gene therapies.
Somatic cell therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmaceutical expertise prior to an organisation implementing somatic cell therapy product.
In-vivo non-GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing in-vivo non-genetically modified organism gene therapies.
Costing clinical trials of ATIMPs using the NIHR iCT
11 February 2026Guidance to support and promote consistent pharmacy costing for commercial clinical trials involving ATIMPs.